Skip to main content
. 2024 Aug 19;24:272. doi: 10.1186/s12876-024-03352-2

Table 2.

Distribution of inappropriate colonoscopies according to EPAGE and EPAGE-II criteria by indications

Inappropriate indications EPAGE I
n (%)
95% CI EPAGE II
n (%)
95% CI
Iron deficiency anemia 4 (2.3) 0.07–4.57 1 (0.7) 0.0001–2.08
Hematochezia 35 (20.3) 14.33–26.36 2 (1.4) 0.0001–3.34
Lower abdominal pain 28 (16.2) 10.76–21.79 60 (42.2) 34.12–50.37
Change in bowel habits 1 (0.5) 0.0001–1.71 2 (1.4) 0.0001–3.34
Uncomplicated Diarrhea 23 (13.3) 8.28–18.45 2 (1.4) 0.0001–3.34
Evaluation of known Ulcerative colitis 22 (12.7) 7.79–17.78 20 (14.0) 8.36–19.80
Evaluation of known Crohn’s disease 14 (8.1) 4.05–12.22 12 (8.4) 3.87–13.02
Surveillance post polypectomy 34 (19.7) 13.81–25.71 39 (27.4) 20.12–34.80
Surveillance after curative intent resection of CRC 2 (1.1) 0.0001–2.76 1 (0.7) 0.0001–2.08
CRC screening 1 (0.5) 0.0001–1.71 1 (0.7) 0.0001–2.08
Other 8 (4.5) 1.50–7.79 2 (1.4) 0.0001–3.34
Total 172 (100) 142 (100)
HHS Vulnerability Disclosure